Martin Crook
Direktor/Vorstandsmitglied bei Cardior Pharmaceuticals GmbH
Profil
Martin Crook is currently a Director at Cardior Pharmaceuticals GmbH.
He obtained a doctorate degree from the University of Bristol in 2000, an undergraduate degree from the University of Lancaster in 1995, and a graduate degree from the University of Birmingham in 1996.
Aktive Positionen von Martin Crook
Unternehmen | Position | Beginn |
---|---|---|
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Direktor/Vorstandsmitglied | - |
Ausbildung von Martin Crook
University of Bristol | Doctorate Degree |
University of Lancaster | Undergraduate Degree |
University of Birmingham | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Health Technology |